Predictors of hospital readmissions in adult patients with sickle cell disease
- PMID: 38223313
- PMCID: PMC10784118
- DOI: 10.62347/ZDET8809
Predictors of hospital readmissions in adult patients with sickle cell disease
Abstract
Background: Sickle cell disease (SCD) is the most common inherited blood disorder, affecting primarily Black and Hispanic individuals. In 2016, 30-day readmissions incurred 95,445 extra days of hospitalization, $152 million in total hospitalization costs, and $609 million in total hospitalization charges.
Objectives: 1) To estimate hospital readmissions within 30 days among patients with SCD in the State of California. 2) Identify the factors associated with readmission within 30 days for SCD patients in California.
Methods: We conducted a retrospective observational study of adult SCD patients hospitalized in California between 2005 and 2014. Descriptive statistics and logistic regression models were used to examine significant differences in patient characteristics and their association with hospital readmissions.
Results: From 2,728 individual index admissions, 70% presented with single admission, 10% experienced one readmission, and 20% experienced ≥ two readmissions within 30 days. Significant predictors associated with zero vs. one readmission were male gender (OR=1.37, CI: 1.06-1.77), Black ethnicity (OR=3.27, CI: 1.71-6.27) and having Medicare coverage (OR=1.89, CI: 1.30-2.75). Lower likelihood of readmission was found in those with a Charlson Comorbidity index of three or more (OR=0.53, CI: 0.29-0.97). For zero vs. ≥ two readmissions, significant predictors were male gender (OR=1.43, CI: 1.17-1.74), Black ethnicity (OR=6.90, CI: 3.41-13.97), Hispanic ethnicity (OR=2.33, CI: 1.05-5.17), Medicare coverage (OR=3.58, CI: 2.68-4.81) and Medi-Cal coverage (OR=1.70, CI: 1.31-2.20). Lower likelihood for having two or more readmissions were associated with individuals aged 65+ (OR=0.97, CI: 0.96-0.98) and those with self-payment status (OR=0.32, CI: 0.12-0.54).
Conclusions: In California, male, Black, and Hispanic patients, as well as those covered by Medicare or Medi-Cal, were found to have an increased risk of hospital readmissions. Redirecting outpatient goals to address these patient populations and risk factors is crucial for reducing readmission rates.
Keywords: Medi-Cal/Medicare; Sickle cell disease; health disparity; hospital readmissions.
AJBR Copyright © 2023.
Conflict of interest statement
None.
Figures
Similar articles
-
Racial and Ethnic Differences in 30-Day Hospital Readmissions Among US Adults With Diabetes.JAMA Netw Open. 2019 Oct 2;2(10):e1913249. doi: 10.1001/jamanetworkopen.2019.13249. JAMA Netw Open. 2019. PMID: 31603490 Free PMC article.
-
Cranial neurosurgical 30-day readmissions by clinical indication.J Neurosurg. 2015 Jul;123(1):189-97. doi: 10.3171/2014.12.JNS14447. Epub 2015 Feb 6. J Neurosurg. 2015. PMID: 25658784
-
Racial/Ethnic Disparities in Readmissions in US Hospitals: The Role of Insurance Coverage.Inquiry. 2018 Jan-Dec;55:46958018774180. doi: 10.1177/0046958018774180. Inquiry. 2018. PMID: 29730971 Free PMC article.
-
Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis.Sci Rep. 2020 Feb 7;10(1):2082. doi: 10.1038/s41598-020-58934-3. Sci Rep. 2020. PMID: 32034210 Free PMC article.
-
Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive Factors.J Sex Med. 2017 Aug;14(8):1059-1065. doi: 10.1016/j.jsxm.2017.06.003. Epub 2017 Jul 12. J Sex Med. 2017. PMID: 28709874
Cited by
-
Hospital Readmissions Among People With Sickle Cell Disease.JAMA Netw Open. 2025 Jun 2;8(6):e2517974. doi: 10.1001/jamanetworkopen.2025.17974. JAMA Netw Open. 2025. PMID: 40526379 Free PMC article.
References
-
- Strouse J. Chapter 18 - sickle cell disease. In: Aminoff MJ, Boller F, Swaab DF, editors. Handbook of Clinical Neurology. Elsevier; 2016. pp. 311–324.
-
- Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010. - PubMed
LinkOut - more resources
Full Text Sources